The present invention concerns methods and means for controlling excessive
proliferation and/or migration of smooth muscle cells, and in particular
for treating stenosis, by using antagonists of a native ErbB4 receptor.
The invention further concerns a method for the identification of ErbB4
agonists and antagonists capable of inhibiting or enhancing the
proliferation or migration of smooth muscle cells.